Skocz do pozycji: 1.

Tytuł:

Effect of an intensive tobacco cessation program on the smoker narrative: A content analysis and grounded theory.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Effect of an intensive tobacco cessation program on the smoker narrative: A content analysis and grounded theory.

Autorzy:

Rábade-Castedo C; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España.
Zamarrón-Sanz C; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Hermida-Ameijeiras Á; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España.; Servicio de Medicina Interna, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Abelleira-Paris R; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Casal-Mouriño A; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Ferreiro-Fernández L; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España.
Rodríguez-Núñez N; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Ricoy-Gabaldón J; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Toubes-Navarro ME; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.
Álvarez-Dobaño JM; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España.
Valdés-Cuadrado L; Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Universitario de Santiago de Compostela, Santiago de Compostela, España.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, España.

Źródło:

Tobacco induced diseases [Tob Induc Dis] 2024 Feb 15; Vol. 22. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 2.

Tytuł:

The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Autorzy:

Gorria T; Medical Oncology, Hospital Clínic, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
Crous C; Medical Oncology, Hospital Clínic, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
Pineda E; Medical Oncology, Hospital Clínic, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
Hernandez A; Medical Oncology, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Domenech M; Medical Oncology, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Sanz C; Pathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Jares P; Department of Pathology, Biomedical Diagnostic Centre (CDB) and Neurological Tissue Bank of the Biobank-IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain.
Muñoz-Mármol AM; Pathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Arpí-Llucía O; Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Melendez B; Molecular Pathology Research Unit, Hospital Universitario de Toledo, 45007 Toledo, Spain.
Gut M; Centro Nacional de Análisis Genómico, C/Baldiri Reixac 4, 08028 Barcelona, Spain.
Esteve A; Medical Oncology, Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.; Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Esteve-Codina A; Centro Nacional de Análisis Genómico, C/Baldiri Reixac 4, 08028 Barcelona, Spain.
Parra G; Centro Nacional de Análisis Genómico, C/Baldiri Reixac 4, 08028 Barcelona, Spain.
Alameda F; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Carrato C; Pathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Aldecoa I; Department of Pathology, Biomedical Diagnostic Centre (CDB) and Neurological Tissue Bank of the Biobank-IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain.
Mallo M; Unidad de Microarrays, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
de la Iglesia N; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Balana C; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.

Źródło:

Cancers [Cancers (Basel)] 2024 Feb 09; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 09.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Different Perspectives of Spanish Patients and Professionals on How a Dialysis Unit Should Be Designed.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Different Perspectives of Spanish Patients and Professionals on How a Dialysis Unit Should Be Designed.

Autorzy:

Arenas Jiménez MD; Renal Foundation, Madrid, Spain.
Manso P; Renal Foundation, Madrid, Spain.
Dapena F; Renal Foundation, Madrid, Spain.
Hernán D; Renal Foundation, Madrid, Spain.
Portillo J; Renal Foundation, Madrid, Spain.
Pereira C; Renal Foundation, Madrid, Spain.
Gallego D; National Federation of Associations for the Fight Against Kidney Diseases (ALCER), Madrid, Spain.
Julián Mauro JC; National Federation of Associations for the Fight Against Kidney Diseases (ALCER), Madrid, Spain.
Arellano Armisen M; National Federation of Associations for the Fight Against Kidney Diseases (ALCER), Madrid, Spain.; Platform of Patient Organizations (POP), Zaragoza, Spain.
Tombas A; Association of Renal Patients of Catalonia (ADER), Barcelona, Spain.
Martin-Crespo Garcia I; Madrid Association for the Fight Against Kidney Diseases, Madrid, Spain.
Gonzalez-Parra E; Hospital Foundation Jiménez Diaz, Madrid, Spain.
Sanz C; Renal Foundation, Madrid, Spain.

Źródło:

Patient preference and adherence [Patient Prefer Adherence] 2023 Nov 01; Vol. 17, pp. 2707-2717. Date of Electronic Publication: 2023 Nov 01 (Print Publication: 2023).

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost-effectiveness study.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost-effectiveness study.

Autorzy:

Toubes-Navarro ME; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Gude-Sampedro F; Department of Clinical Epidemiology, University Clinical Hospital of Santiago de Compostela, Spain.
Álvarez-Dobaño JM; Interdisciplinary Group of research in Pulmonology, Institute of Sanitary research from Compostela, Spain.; University Clinical Hospital of Santiago de Compostela, Spain.
Reyes-Santias F; Department of Human Resources and General Services, University Clinical Hospital of Santiago de Compostela, Spain.
Rábade-Castedo C; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Rodríguez-García C; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Lado-Baleato Ó; Research Methods Group, Health Research Institute of Santiago de Compostela, Spain.; ISCIII Support Platforms for Clinical Research, Health Research Institute of Santiago de Compostela, Spain.
Lago-Fidalgo R; Department of Clinical Epidemiology, University Clinical Hospital of Santiago de Compostela, Spain.; Mathematics University of Santiago de Compostela, Spain.
Sánchez-Martínez N; Department of Clinical Epidemiology, University Clinical Hospital of Santiago de Compostela, Spain.; Mathematics University of Santiago de Compostela, Spain.
Ricoy-Gabaldón J; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Casal-Mouriño A; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Abelleira-Paris R; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Riveiro-Blanco V; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Zamarrón-Sanz C; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Rodríguez-Núñez N; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Lama-López A; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Ferreiro-Fernández L; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.; Interdisciplinary Group of research in Pulmonology, Institute of Sanitary research from Compostela, Spain.
Valdés-Cuadrado L; Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.; Interdisciplinary Group of research in Pulmonology, Institute of Sanitary research from Compostela, Spain.; Medicine University of Santiago de Compostela, Spain.

Źródło:

Annals of thoracic medicine [Ann Thorac Med] 2023 Oct-Dec; Vol. 18 (4), pp. 190-198. Date of Electronic Publication: 2023 Oct 17.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Effectiveness of an exercise intervention based on preactivation of the abdominal transverse muscle in patients with chronic nonspecific low back pain in primary care: a randomized control trial.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Effectiveness of an exercise intervention based on preactivation of the abdominal transverse muscle in patients with chronic nonspecific low back pain in primary care: a randomized control trial.

Autorzy:

Rubí-Carnacea F; Faculty of Nursing and Physiotherapy, Universidad de Lleida, Roig 2, 25198, Lleida, Montserrat, España.; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España.; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España.
Masbernat-Almenara M; Faculty of Nursing and Physiotherapy, Universidad de Lleida, Roig 2, 25198, Lleida, Montserrat, España. .; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España. .; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España. .
Climent-Sanz C; Faculty of Nursing and Physiotherapy, Universidad de Lleida, Roig 2, 25198, Lleida, Montserrat, España.; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España.; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España.
Soler-González J; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España.; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España.; Catalan Institute of Health, Rambla de Ferran 44, 25007, Lleida, España.
García-Escudero M; Faculty of Medicine and Health Sciences, Universidad Católica de Valencia San Vicente Mártir, Valencia, España.
Martínez-Navarro O; Faculty of Nursing and Physiotherapy, Universidad de Lleida, Roig 2, 25198, Lleida, Montserrat, España.; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España.; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España.
Valenzuela-Pascual F; Faculty of Nursing and Physiotherapy, Universidad de Lleida, Roig 2, 25198, Lleida, Montserrat, España.; Group of Studies on Society, Health, Education and Culture (GESEC), Universidad de Lleida, Pl. de Víctor Siurana 1, 25003, Lleida, España.; Research Group of Health Care (GReCS), Lleida Biomedical Research Institute's Dr. Pifarré Foundation (IRB Lleida), Avda Alcalde Rovira Roure 80, 25198, Lleida, España.

Źródło:

BMC primary care [BMC Prim Care] 2023 Sep 06; Vol. 24 (1), pp. 180. Date of Electronic Publication: 2023 Sep 06.

Typ publikacji:

Randomized Controlled Trial; Journal Article

MeSH Terms:

Low Back Pain*/therapy
Adult ; Humans ; Single-Blind Method ; Abdominal Muscles ; Exercise Therapy ; Primary Health Care

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Efficacy of photo-thermal-bioactivated platelet-rich plasma for skin biostimulation in patients not eligible for other medical-aesthetic treatment: A pilot study.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Efficacy of photo-thermal-bioactivated platelet-rich plasma for skin biostimulation in patients not eligible for other medical-aesthetic treatment: A pilot study.

Autorzy:

Hernández Sanz C; Arts Clínic, Valencia, Spain.
Pinto H; i2e3 Biomedical Research Institute, Santa Coloma de Gramenet, Spain.

Źródło:

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2023 Jul; Vol. 29 (7), pp. e13412.

Typ publikacji:

Journal Article

MeSH Terms:

Cosmetic Techniques*/adverse effects
Platelet-Rich Plasma*
Skin Aging*
Humans ; Middle Aged ; Esthetics ; Patient Satisfaction ; Pilot Projects ; Prospective Studies ; Rejuvenation ; Treatment Outcome ; Photothermal Therapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO.

Autorzy:

Textoris L; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
Gragueb-Chatti I; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
Daviet F; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
Valera S; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
Sanz C; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.
Papazian L; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.; Centre Hospitalier de Bastia, Service de Réanimation, 604 Chemin de Falconaja, 20600 Bastia, France.
Forel JM; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.; Centre d'Études et de Recherches sur les Services de Santé et Qualité de vie EA 3279, Aix-Marseille Université, 13005 Marseille, France.
Hraiech S; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.; Centre d'Études et de Recherches sur les Services de Santé et Qualité de vie EA 3279, Aix-Marseille Université, 13005 Marseille, France.
Roch A; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.; Centre d'Études et de Recherches sur les Services de Santé et Qualité de vie EA 3279, Aix-Marseille Université, 13005 Marseille, France.
Guervilly C; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, France.; Centre d'Études et de Recherches sur les Services de Santé et Qualité de vie EA 3279, Aix-Marseille Université, 13005 Marseille, France.

Źródło:

Journal of clinical medicine [J Clin Med] 2023 Jun 08; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 08.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Autorzy:

Pons L; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Hernández L; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Urbizu A; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Osorio P; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Rodríguez-Martínez P; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Castella E; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Muñoz A; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Sanz C; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Arnaldo L; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Felip E; Medical Oncology Department, Catalan Institute of Oncology, B-ARGO Groups, Institut Germans Trias i Pujol (IGTP), 18916 Badalona, Spain.
Quiroga V; Medical Oncology Department, Catalan Institute of Oncology, B-ARGO Groups, Institut Germans Trias i Pujol (IGTP), 18916 Badalona, Spain.
Tapia G; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Margelí M; Medical Oncology Department, Catalan Institute of Oncology, B-ARGO Groups, Institut Germans Trias i Pujol (IGTP), 18916 Badalona, Spain.
Fernandez PL; Department of Pathology, Germans Trias i Pujol Universitary Hospital, Institut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.; Faculty of Medicine and Health Sciences, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain.

Źródło:

Cancers [Cancers (Basel)] 2023 Jun 06; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 06.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Spin-Forbidden Addition of Molecular Oxygen to Stable Enol Intermediates-Decarboxylation of 2-Methyl-1-tetralone-2-carboxylic Acid.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Spin-Forbidden Addition of Molecular Oxygen to Stable Enol Intermediates-Decarboxylation of 2-Methyl-1-tetralone-2-carboxylic Acid.

Autorzy:

Ortega P; Departamento de Química-Física, Universidad de Salamanca, 37008 Salamanca, Spain.
Gil-Guerrero S; Departamento de Química-Física, Universidad de Salamanca, 37008 Salamanca, Spain.; CICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.
González-Sánchez L; Departamento de Química-Física, Universidad de Salamanca, 37008 Salamanca, Spain.
Sanz-Sanz C; Departamento de Química Física Aplicada, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Jambrina PG; Departamento de Química-Física, Universidad de Salamanca, 37008 Salamanca, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Apr 18; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 18.

Typ publikacji:

Journal Article

MeSH Terms:

Tetralones*
Decarboxylation ; Oxygen/chemistry

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

Variation in Juvenile Long Bone Properties as a Function of Age: Mechanical and Compositional Characterization.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Variation in Juvenile Long Bone Properties as a Function of Age: Mechanical and Compositional Characterization.

Autorzy:

Vázquez Sanz C; Instituto de Investigación Tecnológica (IIT), ICAI School of Engineering, Universidad Pontificia Comillas, 28015 Madrid, Spain.
Victoria Rodríguez I; Instituto de Investigación Tecnológica (IIT), ICAI School of Engineering, Universidad Pontificia Comillas, 28015 Madrid, Spain.
Forriol F; Instituto de Investigación Tecnológica (IIT), ICAI School of Engineering, Universidad Pontificia Comillas, 28015 Madrid, Spain.
Tejado E; Departamento de Ciencia de Materiales-CIME, Universidad Politécnica de Madrid, 28015 Madrid, Spain.
Lopez-Valdes FJ; Instituto de Investigación Tecnológica (IIT), ICAI School of Engineering, Universidad Pontificia Comillas, 28015 Madrid, Spain.

Źródło:

Materials (Basel, Switzerland) [Materials (Basel)] 2023 Feb 16; Vol. 16 (4). Date of Electronic Publication: 2023 Feb 16.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Olive Polyphenol Oxidase Gene Family.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Olive Polyphenol Oxidase Gene Family.

Autorzy:

Sánchez R; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa-Spanish National Research Council (IG-CSIC), 41013 Seville, Spain.
Arroyo L; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa-Spanish National Research Council (IG-CSIC), 41013 Seville, Spain.
Luaces P; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa-Spanish National Research Council (IG-CSIC), 41013 Seville, Spain.
Sanz C; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa-Spanish National Research Council (IG-CSIC), 41013 Seville, Spain.
Pérez AG; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa-Spanish National Research Council (IG-CSIC), 41013 Seville, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Feb 06; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 06.

Typ publikacji:

Journal Article

MeSH Terms:

Olea*/chemistry
Plant Oils/metabolism ; Plant Breeding ; Olive Oil/chemistry ; Monophenol Monooxygenase/metabolism ; Phenols/chemistry

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial.

Autorzy:

Vila Méndez ML; Centro de Salud Fronteras, 28850 Torrejón de Ardoz, Spain.
Antón Sanz C; Consultorio Alpedrete, 28430 Alpedrete, Spain.
Cárdenas García ADR; Consultorio Alpedrete, 28430 Alpedrete, Spain.
Bravo Malo A; Centro de Salud Palma Norte, 28015 Madrid, Spain.
Torres Martínez FJ; Centro de Salud Palma Norte, 28015 Madrid, Spain.
Martín Moros JM; Centro de Salud María de Guzmán, 28805 Alcalá de Henares, Spain.
Real Torrijos M; Centro de Salud María de Guzmán, 28805 Alcalá de Henares, Spain.
Vendrell Covisa JFJ; Consultorio Brunete, 28690 Brunete, Spain.
Guzmán Sierra O; Centro de Salud Villalba Estación, 28400 Collado Villalba, Spain.
Molina Barcena V; Centro de Salud Fronteras, 28850 Torrejón de Ardoz, Spain.
Viejo Pinero N; Centro de Salud Fronteras, 28850 Torrejón de Ardoz, Spain.
Fernández Díaz C; Centro de Salud Fronteras, 28850 Torrejón de Ardoz, Spain.
Arroyo Burguillo P; Consultorio Collado Mediano, 28450 Collado Mediano, Spain.
Blanco Gallego AM; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Guirao Sánchez C; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Montilla Bernabé A; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Villanueva Morán MDP; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Juárez Antón S; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Fernández Rodríguez Á; Centro de Salud Benita de Ávila, 28043 Madrid, Spain.
Somoza Calvo MÁ; Consultorio de Moralzarzal-EAP Villalba Pueblo, 28411 Moralzarzal, Spain.
Cerrada EC; Centro de Salud Francia, 28943 Fuenlabrada, Spain.
Pérez Mañas G; Centro de Salud Francia, 28943 Fuenlabrada, Spain.
Sánchez Calso A; Centro de Salud Galapagar, 28260 Galapagar, Spain.
Vallejo Somohano F; Centro de Salud Galapagar, 28260 Galapagar, Spain.
Cauqui Díaz C; Centro de Salud Galapagar, 28260 Galapagar, Spain.
Viñas Fernández G; Centro de Salud Francia, 28943 Fuenlabrada, Spain.
Molina París J; Centro de Salud Francia, 28943 Fuenlabrada, Spain.
González Godoy M; Centro de Salud Francia, 28943 Fuenlabrada, Spain.
Lumbreras García G; Consultorio de Moralzarzal-EAP Villalba Pueblo, 28411 Moralzarzal, Spain.
Rosado Martín J; Centro de Salud Reina Victoria, 28003 Madrid, Spain.
Rodríguez Hernández A; Centro de Salud Reina Victoria, 28003 Madrid, Spain.
López Antúñez S; Centro de Salud Reina Victoria, 28003 Madrid, Spain.
Vázquez Perfecto G; Centro de Salud Dos de Mayo, 28934 Móstoles, Spain.
Marcello Andrés MC; Centro de Salud Galapagar, 28260 Galapagar, Spain.
Puente García NM; Centro de Salud Galapagar, 28260 Galapagar, Spain.
Gil C; Centro de Investigaciones Biológicas 'Margarita Salas' (CSIC), 28040 Madrid, Spain.
Martínez A; Centro de Investigaciones Biológicas 'Margarita Salas' (CSIC), 28040 Madrid, Spain.
Soler López B; E-C-BIO, S.L., Las Rozas, 28230 Madrid, Spain.

Źródło:

Journal of clinical medicine [J Clin Med] 2022 Dec 24; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 24.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World Study.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World Study.

Autorzy:

Tramunt B; Service de Diabétologie, Maladies Métaboliques et Nutrition, CHU et Université de Toulouse, TSA 50032, 31059, Toulouse Cedex 9, France.; Institut des Maladies Métaboliques et Cardiovasculaires, UMR1297 INSERM/UT3, Toulouse, France.
Disse E; Service d'Endocrinologie, Diabète et Nutrition, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
Chevalier N; Université Côte d'Azur, Centre Hospitalier Universitaire, INSERM U1065, C3M, Nice, France.
Bordier L; Service d'Endocrinologie, Hôpital d'instruction des Armées Begin, Saint-Mandé, France.
Cazals L; Service de Diabétologie, Maladies Métaboliques et Nutrition, CHU et Université de Toulouse, TSA 50032, 31059, Toulouse Cedex 9, France.
Dupuy O; Service de Diabétologie et Endocrinologie, Groupe Hospitalier Saint-Joseph, Paris, France.
Marre M; Clinique Ambroise Paré, Neuilly-sur-Seine, France.
Matar O; Service d'Endocrinologie, Diabétologie et Nutrition, Hôpital Bichat, Paris, France.
Meyer L; Service d'Endocrinologie, Diabète et Maladies Métaboliques, CHU de Strasbourg, Strasbourg, France.
Noilhan C; Service de Diabétologie, Maladies Métaboliques et Nutrition, CHU et Université de Toulouse, TSA 50032, 31059, Toulouse Cedex 9, France.
Sanz C; Cabinet d'Endocrinologie, de Diabétologie et de Nutrition, Clinique Pasteur, Toulouse, France.
Valensi P; Unit of Endocrinology, Diabetology and Nutrition, Jean Verdier Hospital, Paris Nord University, Bondy, France.
Velayoudom FL; Service d'Endocrinologie-Diabétologie, CHU de Guadeloupe, Pointe-À-Pitre, France.
Gautier JF; Service de Diabétologie et d'Endocrinologie, Hôpital Lariboisière, AP-HP, Paris Cité, INSERM 1151, Paris, France.; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, 75015, Paris, France.
Gourdy P; Service de Diabétologie, Maladies Métaboliques et Nutrition, CHU et Université de Toulouse, TSA 50032, 31059, Toulouse Cedex 9, France. .; Institut des Maladies Métaboliques et Cardiovasculaires, UMR1297 INSERM/UT3, Toulouse, France. .

Źródło:

Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2022 Dec; Vol. 13 (11-12), pp. 1947-1963. Date of Electronic Publication: 2022 Nov 04.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Using latent profile analysis to understand palliative care professionals' quality of life during the COVID-19 pandemic.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Using latent profile analysis to understand palliative care professionals' quality of life during the COVID-19 pandemic.

Autorzy:

Lluch-Sanz C; Department of Methodology for the Behavioral Sciences, University of Valencia, Av. Blasco Ibañez, 21, 46010 Valencia, Spain.
Galiana L; Department of Methodology for the Behavioral Sciences, University of Valencia, Av. Blasco Ibañez, 21, 46010 Valencia, Spain.
Tomás JM; Department of Methodology for the Behavioral Sciences, University of Valencia, Av. Blasco Ibañez, 21, 46010 Valencia, Spain.
Oliver A; Department of Methodology for the Behavioral Sciences, University of Valencia, Av. Blasco Ibañez, 21, 46010 Valencia, Spain.
Vidal-Blanco G; Department of Nursing, University of Valencia, Valencia, Spain.
Sansó N; Department of Nursing and Physiotherapy, University of the Balearic Islands, Cra. de Valldemossa, Km 7.5, 07120 Palma, Spain.; Balearic Islands Health Research Institute (IDISBA), Palma, Spain.

Źródło:

Current psychology (New Brunswick, N.J.) [Curr Psychol] 2022 Nov 11, pp. 1-13. Date of Electronic Publication: 2022 Nov 11.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 15.

Tytuł:

COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.

Autorzy:

Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Delgado-Sanz C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Monge S; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Infectious Diseases (CIBERINFEC), Madrid, Spain.
Pozo F; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Oliva J; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Sandonis V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Gandarillas A; Subdirección General de Epidemiología, Dirección General de Salud Pública, Madrid, Spain.
Quiñones-Rubio C; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, Logroño, Spain.
Ruiz-Sopeña C; Dirección General de Salud Pública, Junta de Castilla y León, Valladolid, Spain.
Gallardo-García V; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Seville, Spain.
Basile L; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalonia, Spain.
Barranco-Boada MI; Servicio de Epidemiología, Dirección General de Salud Pública, Consejería de Salud, Murcia, Spain.
Hidalgo-Pardo O; Servicio de Medicina Preventiva Hospital Universitario Son Espases, Servicio de Epidemiología, Consellería de Salut, Palma, Spain.
Vazquez-Cancela O; Servicio de Medicina Preventiva, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
García-Vázquez M; Vigilancia Epidemiológica, Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Fernández-Sierra A; Servicio Medicina Preventiva, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Milagro-Beamonte A; Laboratorio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Ordobás M; Subdirección General de Epidemiología, Dirección General de Salud Pública, Madrid, Spain.
Martínez-Ochoa E; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, Logroño, Spain.
Fernández-Arribas S; Dirección General de Salud Pública, Junta de Castilla y León, Valladolid, Spain.
Lorusso N; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Seville, Spain.
Martínez A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalonia, Spain.
García-Fulgueiras A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Servicio de Epidemiología, Dirección General de Salud Pública, Consejería de Salud, Murcia, Spain.
Sastre-Palou B; Servicio de Medicina Preventiva Hospital Universitario Son Espases, Servicio de Epidemiología, Consellería de Salut, Palma, Spain.
Losada-Castillo I; Servizo de Epidemioloxía, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, Spain.
Martínez-Cuenca S; Vigilancia Epidemiológica, Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Rodríguez-Del Águila M; Servicio Medicina Preventiva, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Latorre M; Laboratorio de Microbiología, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Larrauri A; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Corporate Authors:

SARI surveillance VE group in Spain

Źródło:

Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1014-1025. Date of Electronic Publication: 2022 Jul 26.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

COVID-19*/epidemiology
COVID-19*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
COVID-19 Vaccines ; Hospitalization ; Humans ; SARS-CoV-2/genetics ; Sentinel Surveillance ; Spain/epidemiology ; Vaccine Efficacy

SCR Organism:

SARS-CoV-2 variants

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Natural language signatures of psilocybin microdosing.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Natural language signatures of psilocybin microdosing.

Autorzy:

Sanz C; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina. .
Cavanna F; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.; Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Montañeses 2325, C1428 CABA, Buenos Aires, Argentina.
Muller S; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.
de la Fuente L; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.; Institute of Cognitive and Translational Neuroscience, INECO Foundation, Favaloro University, Buenos Aires, Argentina.
Zamberlan F; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.; Department of Cognitive Science and Artificial Intelligence, Tilburg University, Tilburg, the Netherlands.
Palmucci M; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.
Janeckova L; Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic.
Kuchar M; Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic.; Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.
Carrillo F; Applied Artificial Intelligence Lab (ICC-CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.
García AM; Cognitive Neuroscience Center (1644), Universidad de San Andrés, Buenos Aires, Argentina.; National Scientific and Technical Research Council (1425), Buenos Aires, Argentina.; Global Brain Health Institute (94143), University of California-San Francisco, San Francisco, CA, USA.; Global Brain Health Institute (94143), Trinity College Dublin (D02), Dublin, Ireland.; Departamento de Lingüística Y Literatura, Facultad de Humanidades (9160000), Universidad de Santiago de Chile, Santiago, Chile.
Pallavicini C; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina.; Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Montañeses 2325, C1428 CABA, Buenos Aires, Argentina.
Tagliazucchi E; Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), CABA, Buenos Aires, Argentina. .; Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibañez, Santiago, Chile. .

Źródło:

Psychopharmacology [Psychopharmacology (Berl)] 2022 Sep; Vol. 239 (9), pp. 2841-2852. Date of Electronic Publication: 2022 Jun 09.

Typ publikacji:

Journal Article

MeSH Terms:

Hallucinogens*/pharmacology
Mental Disorders*
Adult ; Creativity ; Double-Blind Method ; Female ; Humans ; Language ; Male ; Psilocybin/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.

Autorzy:

Sirera G; Fight AIDS Foundation, Germans Trias i Pujol University Hospital, Badalona, Spain.; Infectious Diseases Department, Germans Trias i Pujol University Hospital, Badalona, Spain.
Videla S; Fight AIDS Foundation, Germans Trias i Pujol University Hospital, Badalona, Spain.; Clinical Research Support Unit (HUB-IDIBELL: Bellvitge University Hospital & Bellvitge Biomedical Research Institute), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, Barcelona, Spain.
Saludes V; Microbiology Department, Laboratori Clinic Metropolitana Nord, Germans Trias i Pujol University Hospital, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Castellà E; Department of Pathology, Germans Trias i Pujol University Hospital, Badalona, Spain.
Sanz C; Department of Pathology, Germans Trias i Pujol University Hospital, Badalona, Spain.
Ariza A; Department of Pathology, Germans Trias i Pujol University Hospital, Badalona, Spain.
Clotet B; Fight AIDS Foundation, Germans Trias i Pujol University Hospital, Badalona, Spain.; IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVIC-UCC), Vic, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Martró E; Microbiology Department, Laboratori Clinic Metropolitana Nord, Germans Trias i Pujol University Hospital, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. .; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. .

Źródło:

Scientific reports [Sci Rep] 2022 Aug 01; Vol. 12 (1), pp. 13196. Date of Electronic Publication: 2022 Aug 01.

Typ publikacji:

Journal Article

MeSH Terms:

Alphapapillomavirus*/genetics
HIV Infections*/complications
HIV Infections*/epidemiology
Lung Neoplasms*/epidemiology
Lung Neoplasms*/genetics
Oncogene Proteins, Viral*/genetics
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
Papillomavirus Infections*/metabolism
DNA, Viral ; Humans ; Papillomaviridae/genetics ; Prevalence ; RNA, Messenger/genetics ; Retrospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.

Autorzy:

Martínez M; Radiology Department, Hospital General Universitario Morales Meseguer, Avda. Marqúes de Los Vélez S/n, Murcia 30007, Spain.
Jiménez S; Radiology Department, Hospital Universitario 12 de Octubre, Av. de Córdoba S/n, Madrid 28041, Spain.
Guzmán F; Radiology Department, Hospital Virgen de La Arrixaca, Ctra. Madrid-Cartagena S/n, Murcia 30120, Spain.
Fernández M; Gynaecology Department, Hospital Universitario Donostia, Begiristain Doktorea Pasealekua, S/n, Donostia 20014, Gipuzkoa, Spain.
Arizaga E; Radiology Department, Hospital Universitario Donostia, Begiristain Doktorea Pasealekua, S/n, Donostia 20014, Gipuzkoa, Spain.
Sanz C; Gynaecology Department, Hospital Universitario 12 de Octubre, Av. de Córdoba, S/n, Madrid 28041, Spain.

Źródło:

The breast journal [Breast J] 2022 Jul 09; Vol. 2022, pp. 6111907. Date of Electronic Publication: 2022 Jul 09 (Print Publication: 2022).

Typ publikacji:

Journal Article; Multicenter Study; Observational Study

MeSH Terms:

Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Breast Neoplasms*/surgery
Neoadjuvant Therapy*
Axilla/pathology ; Female ; Humans ; Lymph Node Excision/methods ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Lymphatic Metastasis/pathology ; Magnets ; Neoplasm Staging ; Prospective Studies ; Sentinel Lymph Node Biopsy/methods

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Very Long Time Persistent HyperCKemia as the First Manifestation of McLeod Syndrome: A Case Report.

Raport

• na półce

Szczegóły

Zmień widok

Tytuł:

Very Long Time Persistent HyperCKemia as the First Manifestation of McLeod Syndrome: A Case Report.

Autorzy:

Torres V; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies Hospital Clínic of Barcelona Barcelona Spain.
Painous C; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies Hospital Clínic of Barcelona Barcelona Spain.
Santacruz P; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies Hospital Clínic of Barcelona Barcelona Spain.
Sánchez A; Biochemistry and Molecular Genetics Department Centre de Diagnòstic Biomèdic, Hospital Clínic of Barcelona Barcelona Spain.
Sanz C; Blood Bank and Transfusion Service Banc de Sang i Teixits, Hospital Clínic of Barcelona Barcelona Spain.
Grau-Junyent JM; Laboratory of Muscle Research and Mitochondrial Function, Department of Internal Medicine Hospital Clínic of Barcelona Barcelona Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; University of Barcelona Barcelona Spain.
Muñoz E; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies Hospital Clínic of Barcelona Barcelona Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; University of Barcelona Barcelona Spain.; European Reference Network-Rare Neurological Diseases (ERN-RND) Barcelona Spain.

Źródło:

Movement disorders clinical practice [Mov Disord Clin Pract] 2022 Jul 03; Vol. 9 (6), pp. 821-824. Date of Electronic Publication: 2022 Jul 03 (Print Publication: 2022).

Typ publikacji:

Case Reports

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers.

Autorzy:

Ortiz-Sanz C; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Llavero F; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Zuazo-Ibarra J; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Balantzategi U; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Quintela-López T; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Wyssenbach A; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Capetillo-Zarate E; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.; IKERBASQUE, Basque Foundation for Science, Plaza Euskadi 5, 48009 Bilbao, Spain.
Matute C; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Alberdi E; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; Department of Neurosciences, Faculty of Medicine and Nursery UPV/EHU and CIBERNED, Barrio de Sarriena s/n, 48940 Leioa, Spain.
Zugaza JL; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, 3rd Floor, Barrio de Sarriena s/n, 48940 Leioa, Spain.; IKERBASQUE, Basque Foundation for Science, Plaza Euskadi 5, 48009 Bilbao, Spain.; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, UPV/EHU, Barrio de Sarriena s/n, 48940 Leioa, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 May 20; Vol. 23 (10). Date of Electronic Publication: 2022 May 20.

Typ publikacji:

Journal Article

MeSH Terms:

Amyloid beta-Peptides*/metabolism
Gliosis*
Integrin beta1*/metabolism
Protein Sorting Signals*
Alzheimer Disease/metabolism ; Animals ; Humans ; Mice

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

• na półce

Szczegóły

Zmień widok

Tytuł:

Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

Autorzy:

Mounié M; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France. .; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France. .
Costa N; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Gourdy P; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.
Latorre C; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Schirr-Bonnans S; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Lagarrigue JM; MSA Midi-Pyrénées Nord, 180 Avenue Marcel UNAL, 82000, Montauban, France.
Roussel H; CNAM, DRSM Occitanie, 2 rue Georges Vivent, 31082, Toulouse, France.
Martini J; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; DIAMIP Network, Toulouse, France.
Buisson JC; ENSEEIHT, Toulouse, France.
Chauchard MC; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; DIAMIP Network, Toulouse, France.
Delaunay J; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Taoui S; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Poncet MF; Claude Bernard Clinic, Albi, France.
Cosma V; Hospital Center, Nîmes, France.
Lablanche S; University Hospital, Grenoble, France.
Coustols-Valat M; Ambroise Paré Clinic, Toulouse, France.
Chaillous L; University Hospital, Nantes, France.
Thivolet C; University Hospital, Lyon, France.
Sanz C; Pasteur Clinic, Toulouse, France.
Penfornis A; Sud Francilien Hospital, Corbeil-Essonnes, and Paris-Saclay University, Corbeil-Essonnes, France.
Lepage B; Department of Epidemiology, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Colineaux H; Department of Epidemiology, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Hanaire H; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.
Molinier L; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Turnin MC; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Benhamou PY
Rodier M
Ayon F
Puel-Olivier F
Fontaine S
Perron M
Arrivié J
Cousty-Pech F
Rouby C
Lafon F
Moura I

Corporate Authors:

Źródło:

Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2022 May; Vol. 13 (5), pp. 1131-1132.

Typ publikacji:

Published Erratum

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

Autorzy:

Mounié M; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France. .; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France. .
Costa N; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Gourdy P; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.
Latorre C; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Schirr-Bonnans S; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Lagarrigue JM; MSA Midi-Pyrénées Nord, 180 Avenue Marcel UNAL, 82000, Montauban, France.
Roussel H; CNAM, DRSM Occitanie, 2 rue Georges Vivent, 31082, Toulouse, France.
Martini J; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; DIAMIP Network, Toulouse, France.
Buisson JC; ENSEEIHT, Toulouse, France.
Chauchard MC; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; DIAMIP Network, Toulouse, France.
Delaunay J; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Taoui S; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Poncet MF; Claude Bernard Clinic, Albi, France.
Cosma V; Hospital Center, Nîmes, France.
Lablanche S; University Hospital, Grenoble, France.
Coustols-Valat M; Ambroise Paré Clinic, Toulouse, France.
Chaillous L; University Hospital, Nantes, France.
Thivolet C; University Hospital, Lyon, France.
Sanz C; Pasteur Clinic, Toulouse, France.
Penfornis A; Sud Francilien Hospital, Corbeil-Essonnes, and Paris-Saclay University, Corbeil-Essonnes, France.
Lepage B; Department of Epidemiology, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Colineaux H; Department of Epidemiology, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Hanaire H; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.
Molinier L; Health-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.; CERPOP, INSERM - University Toulouse III Paul Sabatier, Toulouse, France.
Turnin MC; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.

Corporate Authors:

Źródło:

Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2022 Apr; Vol. 13 (4), pp. 693-708. Date of Electronic Publication: 2022 Feb 08.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

The Infestation of Olive Fruits by Bactrocera oleae (Rossi) Modifies the Expression of Key Genes in the Biosynthesis of Volatile and Phenolic Compounds and Alters the Composition of Virgin Olive Oil.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Infestation of Olive Fruits by Bactrocera oleae (Rossi) Modifies the Expression of Key Genes in the Biosynthesis of Volatile and Phenolic Compounds and Alters the Composition of Virgin Olive Oil.

Autorzy:

Notario A; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Campus UPO, Ctra. Utrera km 1, Bldg. 46, 41013 Seville, Spain.
Sánchez R; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Campus UPO, Ctra. Utrera km 1, Bldg. 46, 41013 Seville, Spain.
Luaces P; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Campus UPO, Ctra. Utrera km 1, Bldg. 46, 41013 Seville, Spain.
Sanz C; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Campus UPO, Ctra. Utrera km 1, Bldg. 46, 41013 Seville, Spain.
Pérez AG; Department of Biochemistry and Molecular Biology of Plant Products, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Campus UPO, Ctra. Utrera km 1, Bldg. 46, 41013 Seville, Spain.

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2022 Mar 02; Vol. 27 (5). Date of Electronic Publication: 2022 Mar 02.

Typ publikacji:

Journal Article

MeSH Terms:

Olea*

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 24.

Tytuł:

Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging.

Autorzy:

Bou-Teen D; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Fernandez-Sanz C; Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Miro-Casas E; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Nichtova Z; Cardiovascular Proteomics Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Bonzon-Kulichenko E; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.; MitoCare Center for Mitochondrial Imaging Research and Diagnostics, Department of Pathology, Anatomy & Cell Biol., Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Casós K; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Inserte J; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Rodriguez-Sinovas A; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Benito B; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Sheu SS; Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Vázquez J; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.; MitoCare Center for Mitochondrial Imaging Research and Diagnostics, Department of Pathology, Anatomy & Cell Biol., Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ferreira-González I; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Ruiz-Meana M; Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.

Źródło:

Aging cell [Aging Cell] 2022 Mar; Vol. 21 (3), pp. e13564. Date of Electronic Publication: 2022 Mar 02.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Aging*/metabolism
Aging*/physiology
Mitochondria, Heart*/metabolism
Mitochondrial Proton-Translocating ATPases*/chemistry
Mitochondrial Proton-Translocating ATPases*/metabolism
Myocytes, Cardiac*/metabolism
Adenosine Triphosphate/metabolism ; Animals ; Calcium/metabolism ; Dimerization ; Glycation End Products, Advanced/chemistry ; Glycation End Products, Advanced/metabolism ; Mice ; Mitochondrial Permeability Transition Pore

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients.

Autorzy:

Montero P; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Pérez-Leal M; Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Cancer (CIBERONC), Health Institute Carlos III, 28029 Madrid, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Sanz C; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Health Sciences, Pre-Departmental Section of Medicine, Jaume I University of Castellón de la Plana, 12071 Castellón, Spain.
Estornut C; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Roger I; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Milara J; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.; Pharmacy Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Cervantes A; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Cortijo J; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.; Research and Teaching Unit, University General Hospital Consortium, 46014 Valencia, Spain.

Źródło:

Cancers [Cancers (Basel)] 2022 Feb 23; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 23.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model.

Autorzy:

Montero P; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Milara J; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.; Pharmacy Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Pérez-Leal M; Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Estornut C; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Roger I; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Pérez-Fidalgo A; Department of Medical Oncology, University Clinic Hospital of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Cancer (CIBERONC), Health Institute Carlos III, 28029 Madrid, Spain.; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Sanz C; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Health Sciences, Pre-Departmental Section of Medicine, Jaume I University of Castellon, 12071 Castellon, Spain.
Cortijo J; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.; Research and Teaching Unit, University General Hospital Consortium, 46014 Valencia, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 Jan 20; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 20.

Typ publikacji:

Journal Article

MeSH Terms:

Cytokines/*metabolism
Epidermis/*metabolism
Keratinocytes/*cytology
Paclitaxel/*adverse effects
Reactive Oxygen Species/*metabolism
Toll-Like Receptor 4/*metabolism
Animals ; BALB 3T3 Cells ; Cell Survival/drug effects ; Cells, Cultured ; Dermis/cytology ; Dermis/drug effects ; Dermis/metabolism ; Endothelial Cells/cytology ; Endothelial Cells/drug effects ; Endothelial Cells/metabolism ; Epidermis/drug effects ; Gene Expression Regulation/drug effects ; Humans ; Interleukin-1alpha/metabolism ; Interleukin-6/metabolism ; Interleukin-8/metabolism ; Keratinocytes/drug effects ; Keratinocytes/metabolism ; Mice ; NF-kappa B/metabolism ; Paclitaxel/pharmacology ; Phosphorylation/drug effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy.

Autorzy:

Peña-Martín MC; Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain.
García-Berrocal B; Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain.
Sánchez-Martín A; Department of Pharmacy, University Hospital of Salamanca, 37007 Salamanca, Spain.
Marcos-Vadillo E; Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain.
García-Salgado MJ; Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain.
Sánchez S; Department of Psychiatry, University Hospital of Salamanca, 37007 Salamanca, Spain.
Lorenzo C; Department of Psychiatry, University Hospital of Salamanca, 37007 Salamanca, Spain.
González-Parra D; Department of Psychiatry, University Hospital of Salamanca, 37007 Salamanca, Spain.
Sans F; Psychiatry and Mental Health Department, Healthcare Complex of Zamora, 49022 Zamora, Spain.
Franco M; Psychiatry and Mental Health Department, Healthcare Complex of Zamora, 49022 Zamora, Spain.; Psychiatry and Mental Health Department, University Rio Hortega Hospital, 47012 Valladolid, Spain.; Biomedicine Research Institute (IBSAL), PETRA Department, 37007 Salamanca, Spain.
Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy, Kansas City, MO 64108, USA.
Mateos-Sexmero MJ; Psychiatry and Mental Health Department, University Hospital of Valladolid, 47003 Valladolid, Spain.
Sanz C; Department of Microbiology and Genetics, University of Salamanca, IBSAL, 37007 Salamanca, Spain.
Isidoro-García M; Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain.; Department of Medicine, University of Salamanca, IBSAL, 37007 Salamanca, Spain.

Źródło:

Pharmaceutics [Pharmaceutics] 2022 Jan 11; Vol. 14 (1). Date of Electronic Publication: 2022 Jan 11.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 Deaths.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 Deaths.

Autorzy:

León-Gómez I; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Mazagatos C; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Delgado-Sanz C; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Frías L; CIRCITER S.L., 28005 Madrid, Spain.
Vega-Piris L; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.
Rojas-Benedicto A; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Larrauri A; National Centre of Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.

Źródło:

Viruses [Viruses] 2021 Dec 03; Vol. 13 (12). Date of Electronic Publication: 2021 Dec 03.

Typ publikacji:

Journal Article

MeSH Terms:

Pandemics*
COVID-19/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Epidemiological Monitoring ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Public Health ; SARS-CoV-2 ; Spain/epidemiology ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 29.

Tytuł:

Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries.

Autorzy:

Staadegaard L; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Caini S; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Wangchuk S; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
Thapa B; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
de Almeida WAF; Department of Immunization and Communicable Diseases, Ministry of Health, Brasilia, Brazil.
de Carvalho FC; Department of Immunization and Communicable Diseases, Ministry of Health, Brasilia, Brazil.
Fasce RA; Subdepartamento Enfermedades Virales, Instituto de Salud Pública de Chile, Santiago, Chile.
Bustos P; Sección Virus Respiratorios, Subdepartamento Enfermedades Virales, Instituto de Salud Publica de Chile, Santiago, Chile.
Kyncl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Novakova L; National Reference Laboratory for Influenza and Other Respiratory Viruses, National Institute of Public Health, Prague, Czech Republic.
Caicedo AB; Universidad Agraria del Ecuador, Guayaquil, Ecuador.; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
de Mora Coloma DJ; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Meijer A; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Huang QS; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Wood T; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Guiomar R; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Lee VJM; Ministry of Health, Singapore.; Saw Swee Hock School of Public Health, Singapore.
Ang LW; Ministry of Health, Singapore.; National Centre for Infectious Diseases, Singapore.
Cohen C; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Moyes J; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Delgado-Sanz C; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Demont C; Sanofi Pasteur, Lyon, France.
Bangert M; Sanofi Pasteur, Lyon, France.
Dückers M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
van Summeren J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Paget J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

Źródło:

Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2021 Nov; Vol. 15 (6), pp. 732-741. Date of Electronic Publication: 2021 Jul 13.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Epidemics*
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*/epidemiology
Humans ; Infant ; Seasons ; United States/epidemiology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 30.

Tytuł:

Combination Therapy of Allopurinol and Dantrolene and Its Role In The Prevention of Experimental Ischemia Reperfusion Injury Of The Small Intestine.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Combination Therapy of Allopurinol and Dantrolene and Its Role In The Prevention of Experimental Ischemia Reperfusion Injury Of The Small Intestine.

Autorzy:

Prieto-Moure B; Department of Biomedical Sciences, European University of Valencia, Valencia, Spain.
Cejalvo-Lapeña D; Research Group 'Identification Therapeutic and Experimental Evaluation of Natural Products Bioprotectors,' Faculty of Medicine and Experimental, Catholic University of Valencia, Valencia, Spain.
Belda-Antolí M; Research Group 'Identification Therapeutic and Experimental Evaluation of Natural Products Bioprotectors,' Faculty of Medicine and Experimental, Catholic University of Valencia, Valencia, Spain.
Padrón-Sanz C; Research Group 'Identification Therapeutic and Experimental Evaluation of Natural Products Bioprotectors,' Faculty of Medicine and Experimental, Catholic University of Valencia, Valencia, Spain.
Lloris-Cejalvo JM; Research Group 'Identification Therapeutic and Experimental Evaluation of Natural Products Bioprotectors,' Faculty of Medicine and Experimental, Catholic University of Valencia, Valencia, Spain.
Lloris-Carsí JM; Faculty of Medicine, University of Valencia, Valencia, Spain.

Źródło:

Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2021 Jul; Vol. 34 (7), pp. 800-807. Date of Electronic Publication: 2020 Jan 06.

Typ publikacji:

Journal Article

MeSH Terms:

Allopurinol*/therapeutic use
Reperfusion Injury*/prevention & control
Animals ; Dantrolene ; Intestine, Small ; Male ; Rats ; Rats, Wistar ; Superoxide Dismutase

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the .

Autorzy:

Turnin MC; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France. .
Gourdy P; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.
Martini J; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.; DIAMIP Network, Toulouse, France.
Buisson JC; ENSEEIHT, Toulouse, France.
Chauchard MC; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.; DIAMIP Network, Toulouse, France.
Delaunay J; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
Schirr-Bonnans S; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
Taoui S; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.
Poncet MF; Claude Bernard Clinic, Albi, France.
Cosma V; Nîmes Hospital Centre, Nimes, France.
Lablanche S; University Hospital, Grenoble, France.
Coustols-Valat M; Ambroise Paré Clinic, Toulouse, France.
Chaillous L; University Hospital, Nantes, France.
Thivolet C; University Hospital, Lyon, France.
Sanz C; Pasteur Clinic, Toulouse, France.
Penfornis A; Sud Francilien Hospital, Corbeil-Essonnes and Paris-Saclay University, Paris, France.
Lepage B; University Department of Epidemiology, Health Economics and Public Health, University Hospital, Toulouse, France.
Colineaux H; University Department of Epidemiology, Health Economics and Public Health, University Hospital, Toulouse, France.
Mounié M; Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Costa N; Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Molinier L; Medico-Economic Unit, Medical Information Department, University Hospital, Toulouse, France.
Hanaire H; Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, 1 Avenue Jean Poulhès, TSA 50032, Toulouse cedex 9, 31059, Toulouse, France.; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.

Corporate Authors:

Źródło:

Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2021 Jul; Vol. 12 (7), pp. 2059-2075. Date of Electronic Publication: 2021 Jun 23.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 32.

Tytuł:

GoRG: Towards a GPU-Accelerated Multiview Hyperspectral Depth Estimation Tool for Medical Applications.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

GoRG: Towards a GPU-Accelerated Multiview Hyperspectral Depth Estimation Tool for Medical Applications.

Autorzy:

Sancho J; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.
Sutradhar P; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.
Rosa G; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.
Chavarrías M; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.
Perez-Nuñez A; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Salvador R; CentraleSupélec, CNRS, IETR, UMR 6164, 35700 Rennes, France.
Lagares A; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Juárez E; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.
Sanz C; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), 28031 Madrid, Spain.

Źródło:

Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 Jun 14; Vol. 21 (12). Date of Electronic Publication: 2021 Jun 14.

Typ publikacji:

Journal Article

MeSH Terms:

Algorithms*
Brain Neoplasms*
Brain ; Humans ; Magnetic Resonance Imaging

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 33.

Tytuł:

Polymorphisms in canine immunoglobulin heavy chain gene cluster: a double-edged sword for diabetes mellitus in the dog.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Polymorphisms in canine immunoglobulin heavy chain gene cluster: a double-edged sword for diabetes mellitus in the dog.

Autorzy:

Sanz CR; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Madrid, 28040, Spain.
Sevane N; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Madrid, 28040, Spain.
Pérez-Alenza MD; Department of Animal Medicine, Surgery and Pathology, Veterinary Faculty, Complutense University of Madrid, Madrid, 28040, Spain.
Valero-Lorenzo M; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Madrid, 28040, Spain.
Dunner S; Department of Animal Production, Veterinary Faculty, Complutense University of Madrid, Madrid, 28040, Spain.

Źródło:

Animal genetics [Anim Genet] 2021 Jun; Vol. 52 (3), pp. 333-341. Date of Electronic Publication: 2021 Feb 23.

Typ publikacji:

Journal Article

MeSH Terms:

Genes, Immunoglobulin Heavy Chain*
Multigene Family*
Diabetes Mellitus/*veterinary
Dog Diseases/*genetics
Dogs/*genetics
Animals ; Breeding ; Diabetes Mellitus/genetics ; Genetic Predisposition to Disease ; Genome ; Genome-Wide Association Study/veterinary ; Polymorphism, Single Nucleotide

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 34.

Tytuł:

Atrial cholangiocarcinoma diagnosed by cardiac magnetic resonance imaging.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Atrial cholangiocarcinoma diagnosed by cardiac magnetic resonance imaging.

Autorzy:

Marschall A; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Rodriguez Torres D; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Rueda Liñares A; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Del Castillo Carnevali H; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Dejuán Bitriá C; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Fraile Sanz C; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Duarte Torres J; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Álvarez Antón S; Department of Cardiology, Central defense Hospital, Madrid, Spain.
Martí Sánchez D; Department of Cardiology, Central defense Hospital, Madrid, Spain.

Źródło:

Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2021 Jun; Vol. 38 (6), pp. 1089-1092. Date of Electronic Publication: 2021 May 19.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Bile Duct Neoplasms*/diagnostic imaging
Cholangiocarcinoma*/diagnostic imaging
Aged, 80 and over ; Bile Ducts, Intrahepatic ; Heart Atria/diagnostic imaging ; Humans ; Magnetic Resonance Imaging ; Male

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 35.

Tytuł:

Supervised Machine Learning Methods and Hyperspectral Imaging Techniques Jointly Applied for Brain Cancer Classification.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Supervised Machine Learning Methods and Hyperspectral Imaging Techniques Jointly Applied for Brain Cancer Classification.

Autorzy:

Urbanos G; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Martín A; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Vázquez G; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Villanueva M; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Villa M; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Jimenez-Roldan L; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Chavarrías M; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Lagares A; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Juárez E; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.
Sanz C; Research Center on Software Technologies and Multimedia Systems (CITSEM), Universidad Politécnica de Madrid (UPM), Campus Sur UPM, 28031 Madrid, Spain.

Źródło:

Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 May 31; Vol. 21 (11). Date of Electronic Publication: 2021 May 31.

Typ publikacji:

Journal Article

MeSH Terms:

Brain Neoplasms*/diagnostic imaging
Hyperspectral Imaging*
Humans ; Machine Learning ; Neural Networks, Computer ; Supervised Machine Learning ; Support Vector Machine

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 36.

Tytuł:

The age again in the eye of the COVID-19 storm: evidence-based decision making.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The age again in the eye of the COVID-19 storm: evidence-based decision making.

Autorzy:

Martín MC; Centro de Hemoterapia y Hemodonación de Castilla y León, Valladolid, Spain.
Jurado A; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain. .
Abad-Molina C; Department of Microbiology and Immunology, Hospital Clínico Universitario, Valladolid, Spain.
Orduña A; Department of Microbiology and Immunology, Hospital Clínico Universitario, Valladolid, Spain.
Yarce O; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.
Navas AM; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.
Cunill V; Department of Immunology, Hospital Universitario Son Espases-Human Immunopathology Research Laboratory, Institut d'Investigació Sanitària de les Illes Balears (IdISBa), Palma de Mallorca, Spain.
Escobar D; Department of Immunology, Hospital Universitario Son Espases-Human Immunopathology Research Laboratory, Institut d'Investigació Sanitària de les Illes Balears (IdISBa), Palma de Mallorca, Spain.
Boix F; Department of Immunology, Hospital Clínico Universitario, Salamanca, Spain.
Burillo-Sanz S; Department of Immunology, Hospital Clínico Universitario, Salamanca, Spain.
Vegas-Sánchez MC; Department of Immunology, Fundación Jiménez Díaz, Madrid, Spain.
Jiménez-de Las Pozas Y; Department of Immunology, Fundación Jiménez Díaz, Madrid, Spain.
Melero J; Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain.
Aguilar M; Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain.
Sobieschi OI; Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain.
López-Hoyos M; Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Ocejo-Vinyals G; Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
San Segundo D; Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Almeida D; Laboratory of Immunology, Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
Medina S; Laboratory of Immunology, Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
Fernández L; Laboratoy of Immunology and Genetics, Hospital San Pedro de Alcántara, Cáceres, Spain.
Vergara E; Laboratoy of Immunology and Genetics, Hospital San Pedro de Alcántara, Cáceres, Spain.
Quirant B; Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain.
Martínez-Cáceres E; Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain.
Boiges M; Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain.
Alonso M; Department of Immunology, Hospital de Cruces, Baracaldo, Spain.
Esparcia-Pinedo L; Department of Immunology, Hospital Universitario La Princesa, Madrid, Spain.
López-Sanz C; Department of Immunology, Hospital Universitario La Princesa, Madrid, Spain.
Muñoz-Vico J; Department of Immunology, Hospital Torrecárdenas, Almería, Spain.
López-Palmero S; Department of Immunology, Hospital Torrecárdenas, Almería, Spain.
Trujillo A; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.
Álvarez P; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.
Prada Á; Department of Immunology, Hospital de Donostia, San Sebastián, Spain.
Monzón D; Department of Immunology, Hospital de Donostia, San Sebastián, Spain.
Ontañón J; Unit of Immunology, Hospital General Universitario, Albacete, Spain.
Marco FM; Laboratory Unit, Hospital General, Alicante, Spain.
Mora S; Laboratory Unit, Hospital General, Alicante, Spain.
Rojo R; Department of Immunology, Complejo Hospitalario, La Coruña, Spain.
González-Martínez G; Unit of Immunology, Hospital Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.
Martínez-Saavedra MT; Unit of Immunology, Hospital Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.
Gil-Herrera J; Department of Immunology, Hospital General Universitario e Instituto de Investigación Sanitaria, 'Gregorio Marañón', Madrid, Spain.
Cantenys-Molina S; Department of Immunology, Hospital General Universitario e Instituto de Investigación Sanitaria, 'Gregorio Marañón', Madrid, Spain.
Hernández M; Department of Immunology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Perurena-Prieto J; Department of Immunology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Rodríguez-Bayona B; Laboratory Unit, Hospital Juan Ramón Jiménez, Huelva, Spain.
Martínez A; Laboratory Unit, Complejo Hospitalario, Jaén, Spain.
Ocaña E; Laboratory Unit, Complejo Hospitalario, Jaén, Spain.
Molina J; Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.

Źródło:

Immunity & ageing : I & A [Immun Ageing] 2021 May 20; Vol. 18 (1), pp. 24. Date of Electronic Publication: 2021 May 20.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 37.

Tytuł:

The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.

Autorzy:

Carrato C; Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Sanz C; Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Muñoz-Mármol AM; Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Blanco I; Program on Clinical Genetics and Genetic Counseling, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Pineda M; Hereditary Cancer Program, ONCOBELL Program, Hospitalet de Llobregat, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitaled de Liobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28040 Madrid, Spain.
Del Valle J; Hereditary Cancer Program, ONCOBELL Program, Hospitalet de Llobregat, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitaled de Liobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28040 Madrid, Spain.
Dámaso E; Hereditary Cancer Program, ONCOBELL Program, Hospitalet de Llobregat, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitaled de Liobregat, Spain.
Esteller M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28040 Madrid, Spain.; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), 08007 Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.
Musulen E; Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.; Department of Pathology, Hospital Universitari General de Catalunya-Grupo QuirónSalud, 08195 Sant Cugat del Vallès, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2021 Apr 28; Vol. 22 (9). Date of Electronic Publication: 2021 Apr 28.

Typ publikacji:

Case Reports; Journal Article; Review

MeSH Terms:

Brain Neoplasms/*diagnosis
Colorectal Neoplasms/*diagnosis
DNA-Binding Proteins/*genetics
Neoplastic Syndromes, Hereditary/*diagnosis
Brain Neoplasms/genetics ; Child, Preschool ; Colorectal Neoplasms/genetics ; Diagnosis, Differential ; Female ; Humans ; Neoplastic Syndromes, Hereditary/genetics ; Neurofibromatoses/diagnosis

SCR Disease Name:

Turcot syndrome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 38.

Tytuł:

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.

Autorzy:

Mendonça de Pontes R; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil.
Flores-Montero J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.
Sanoja-Flores L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Institute of Biomedicine of Seville, Department of Hematology, University Hospital Virgen del Rocío of the Consejo Superior de Investigaciones Científicas (CSIC), University of Seville, 41013 Seville, Spain.
Puig N; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain.
Pessoa de Magalhães RJ; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.
Corral-Mateos A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.
Salgado AB; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.
García-Sánchez O; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain.
Pérez-Morán J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain.
Mateos MV; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain.
Burgos L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Paiva B; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Te Marvelde J; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands.
van der Velden VHJ; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands.
Aguilar C; Department of Hematology, Hospital General de Santa Bárbara, 42005 Soria, Spain.
Bárez A; Department of Hematology, Complejo Asistencial de Ávila, 05071 Ávila, Spain.
García-Mateo A; Department of Hematology, Complejo Asistencial de Segovia, 40002 Segovia, Spain.
Labrador J; Department of Hematology and Research Unit, Hospital Universitario de Burgos, 09006 Burgos, Spain.
Leoz P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain.
Aguilera-Sanz C; Department of Hematology, Hospital El Bierzo, 24404 Ponferrada, Spain.
Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA 90048, USA.
van Dongen JJM; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Maiolino A; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Americas Centro de Oncologia Integrado, Rio de Janeiro 22290-030, Brazil.
Sobral da Costa E; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil.
Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.

Źródło:

Cancers [Cancers (Basel)] 2021 Apr 03; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 03.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Neurological symptoms in Covid-19 patients in the emergency department.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Neurological symptoms in Covid-19 patients in the emergency department.

Autorzy:

García-Azorín D; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Trigo J; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Martínez-Pías E; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Hernández-Pérez I; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Valle-Peñacoba G; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Talavera B; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Simón-Campo P; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
de Lera M; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Chavarría-Miranda A; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
López-Sanz C; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Gutiérrez-Sánchez M; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Martínez-Velasco E; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Pedraza M; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Sierra Á; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Gómez-Vicente B; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Guerrero Á; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.
Arenillas JF; Department of Neurology. Hospital, Clínico Universitario de Valladolid, Valladolid, Spain.

Źródło:

Brain and behavior [Brain Behav] 2021 Apr; Vol. 11 (4), pp. e02058. Date of Electronic Publication: 2021 Feb 22.

Typ publikacji:

Journal Article

MeSH Terms:

Emergency Service, Hospital*
COVID-19/*physiopathology
COVID-19/*psychology
Aged ; COVID-19/mortality ; Female ; Hospital Mortality ; Humans ; Male ; Retrospective Studies ; Spain/epidemiology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 40.

Tytuł:

The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries.

Autorzy:

Staadegaard L; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Caini S; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Wangchuk S; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
Thapa B; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
de Almeida WAF; Ministry of Health, Brasilia, Brazil.
de Carvalho FC; Ministry of Health, Brasilia, Brazil.
Njouom R; Service de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
Fasce RA; Subdepartamento Enfermedades Virales, Instituto de Salud Pública de Chile, Santiago, Chile.
Bustos P; Sección Virus Respiratorios, Subdepartamento Enfermedades Virales, Instituto de Salud Publica de Chile, Santiago, Chile.
Kyncl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Novakova L; National Reference Laboratory for Influenza and Other Respiratory Viruses, National Institute of Public Health, Prague, Czech Republic.
Caicedo AB; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.; Universidad Agraria del Ecuador, Guayaquil, Ecuador.
de Mora Coloma DJ; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Meijer A; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Huang S; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Wood T; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Guiomar R; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Danilenko D; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation.
Stolyarov K; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation.
Lee VJM; Ministry of Health, Singapore.; Saw Swee Hock School of Public Health, Singapore.
Ang LW; Ministry of Health, Singapore.; National Centre for Infectious Diseases, Singapore.
Cohen C; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Moyes J; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Delgado-Sanz C; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Le MQ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Hoang PVM; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Demont C; Sanofi Pasteur, Lyon, France.
Bangert M; Sanofi Pasteur, Lyon, France.
van Summeren J; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Dückers M; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.; ARQ National Psychotrauma Centre, Diemen, the Netherlands.; Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.
Paget J; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.

Źródło:

Open forum infectious diseases [Open Forum Infect Dis] 2021 Mar 30; Vol. 8 (7), pp. ofab159. Date of Electronic Publication: 2021 Mar 30 (Print Publication: 2021).

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses.

Autorzy:

Cequier A; Laboratorio de Genética Bioquímica LAGENBIO-Instituto de Investigación Sanitaria de Aragón (IIS)-Instituto Agroalimentario de Aragón (IA2), Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Sanz C; Servicio de Cirugía y Medicina Equina, Hospital Veterinario, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Rodellar C; Laboratorio de Genética Bioquímica LAGENBIO-Instituto de Investigación Sanitaria de Aragón (IIS)-Instituto Agroalimentario de Aragón (IA2), Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.
Barrachina L; Laboratorio de Genética Bioquímica LAGENBIO-Instituto de Investigación Sanitaria de Aragón (IIS)-Instituto Agroalimentario de Aragón (IA2), Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.; Servicio de Cirugía y Medicina Equina, Hospital Veterinario, Universidad de Zaragoza, C/Miguel Servet, 177, 50013 Zaragoza, Spain.

Źródło:

Animals : an open access journal from MDPI [Animals (Basel)] 2021 Mar 25; Vol. 11 (4). Date of Electronic Publication: 2021 Mar 25.

Typ publikacji:

Journal Article; Review

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

Recent genetic connectivity and clinal variation in chimpanzees.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Recent genetic connectivity and clinal variation in chimpanzees.

Autorzy:

Lester JD; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany. jack_.
Vigilant L; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Gratton P; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
McCarthy MS; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Barratt CD; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.
Dieguez P; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Agbor A; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Álvarez-Varona P; Jane Goodall Institute Spain and Senegal, Dindefelo Biological Station, Dindefelo, Kedougou, Senegal.
Angedakin S; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Ayimisin EA; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Bailey E; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Bessone M; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Brazzola G; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Chancellor R; West Chester University, Depts of Anthropology & Sociology and Psychology, West Chester, PA, USA.
Cohen H; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Danquah E; Department of Wildlife and Range Management, Faculty of Renewable Natural Resources, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Deschner T; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Egbe VE; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Eno-Nku M; WWF Cameroon Country Programme Office, Yaoundé, Cameroon.
Goedmakers A; Chimbo Foundation, Amsterdam, Netherlands.
Granjon AC; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Head J; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Hedwig D; Elephant Listening Project, Center for Conservation Bioacoustics, Cornell Lab of Ornithology, Cornell University, Ithaca, NY, USA.
Hernandez-Aguilar RA; Jane Goodall Institute Spain and Senegal, Dindefelo Biological Station, Dindefelo, Kedougou, Senegal.; Department of Social Psychology and Quantitative Psychology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.
Jeffery KJ; Biological and Environmental Sciences, Faculty of Natural Sciences, University of Stirling, Stirling, UK.
Jones S; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Junker J; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Kadam P; University of Cambridge, Cambridge, UK.
Kaiser M; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Kalan AK; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Kehoe L; Wild Chimpanzee Foundation (WCF), Leipzig, Germany.
Kienast I; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Langergraber KE; School of Human Evolution and Social Change, Arizona State University, 900 Cady Mall, Tempe, AZ 85287 Arizona State University, Tempe, AZ, USA.
Lapuente J; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.; Comoé Chimpanzee Conservation Project, Comoé National Park, Kakpin, Côte d'Ivoire.
Laudisoit A; Ecohealth Alliance, New York, NY, USA.; University of Antwerp, Campus Drie Eiken, lokaal D.133, Universiteitsplein 1 - 2610, Antwerpen, Belgium.
Lee K; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Marrocoli S; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Mihindou V; Agence National des Parcs Nationaux (ANPN) Batterie 4, Libreville, Gabon.; Ministère des Eaux, des Forêts, de la Mer, de l'Environnement, Chargé du Plan Climat, des Objectifs de Développement Durable et du Plan d'Affectation des Terres, Libreville, Gabon.
Morgan D; Lester E. Fisher Center for the Study and Conservation of Apes, Lincoln Park Zoo, Chicago, IL, USA.
Muhanguzi G; Budongo Conservation Field Station, Masindi, Uganda.
Neil E; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Nicholl S; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Orbell C; Panthera, New York, NY, USA.
Ormsby LJ; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Pacheco L; Jane Goodall Institute Spain and Senegal, Dindefelo Biological Station, Dindefelo, Kedougou, Senegal.
Piel A; Department of Anthropology, University College London, London, UK.
Robbins MM; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Rundus A; West Chester University, Department of Psychology, West Chester, PA, USA.
Sanz C; Washington University in Saint Louis, Department of Anthropology, One Brookings Drive, St. Louis, MO, USA.; Wildlife Conservation Society, Congo Program, Brazzaville, Republic of Congo.
Sciaky L; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Siaka AM; National Protected Area Authority, Freetown, Sierra Leone.
Städele V; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Stewart F; School of Biological & Environmental Sciences, Liverpool John Moores University, Liverpool, UK.
Tagg N; KMDA, Centre for Research and Conservation, Royal Zoological Society of Antwerp, Antwerp, Belgium.
Ton E; Chimbo Foundation, Amsterdam, Netherlands.
van Schijndel J; Chimbo Foundation, Amsterdam, Netherlands.
Vyalengerera MK; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Wessling EG; Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
Willie J; KMDA, Centre for Research and Conservation, Royal Zoological Society of Antwerp, Antwerp, Belgium.
Wittig RM; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.; Taï Chimpanzee Project, Centre Suisse de Recherches Scientifiques, Abidjan, Côte d'Ivoire.
Yuh YG; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Yurkiw K; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.; Pan Verus Project Outamba-Kilimi National Park, Freetown, Sierra Leone.
Zuberbuehler K; Budongo Conservation Field Station, Masindi, Uganda.; Université de Neuchâtel, Institut de Biologie, Neuchâtel, Switzerland.; School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK.
Boesch C; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.
Kühl HS; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany.; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.
Arandjelovic M; Max Planck Institute for Evolutionary Anthropology (MPI EVAN), Leipzig, Germany. .

Źródło:

Communications biology [Commun Biol] 2021 Mar 05; Vol. 4 (1), pp. 283. Date of Electronic Publication: 2021 Mar 05.

Typ publikacji:

Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Behavior, Animal*
Evolution, Molecular*
Genetic Variation*
Genome Components*
Microsatellite Repeats*
Pan troglodytes/*genetics
Animal Migration ; Animals ; Ecosystem ; Gene-Environment Interaction ; Genetics, Population ; Pan troglodytes/psychology ; Phylogeny ; Species Specificity

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

DpgC-Catalyzed Peroxidation of 3,5-Dihydroxyphenylacetyl-CoA (DPA-CoA): Insights into the Spin-Forbidden Transition and Charge Transfer Mechanisms*.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

DpgC-Catalyzed Peroxidation of 3,5-Dihydroxyphenylacetyl-CoA (DPA-CoA): Insights into the Spin-Forbidden Transition and Charge Transfer Mechanisms*.

Autorzy:

Ortega P; Departamento de Química Física, University of Salamanca, Salamanca, 37008, Spain.
Zanchet A; Departamento de Química Física, University of Salamanca, Salamanca, 37008, Spain.; Instituto de Física Fundamental (CSIC), Madrid, 28006, Spain.
Sanz-Sanz C; Departamento de Química Física Aplicada, University Autónoma de Madrid, Madrid, 28049, Spain.
Gómez-Carrasco S; Departamento de Química Física, University of Salamanca, Salamanca, 37008, Spain.
González-Sánchez L; Departamento de Química Física, University of Salamanca, Salamanca, 37008, Spain.
Jambrina PG; Departamento de Química Física, University of Salamanca, Salamanca, 37008, Spain.

Źródło:

Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2021 Jan 21; Vol. 27 (5), pp. 1700-1712. Date of Electronic Publication: 2020 Dec 14.

Typ publikacji:

Journal Article

MeSH Terms:

Biocatalysis*
Coenzyme A/*chemistry
Coenzyme A/*metabolism
Oxygenases/*metabolism
Electron Transport ; Oxygenases/chemistry ; Quantum Theory

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Stick around: Cell-Cell Adhesion Molecules during Neocortical Development.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Stick around: Cell-Cell Adhesion Molecules during Neocortical Development.

Autorzy:

de Agustín-Durán D; Neural Development Laboratory, Instituto Universitario de Biomedicina y Biotecnología (BIOTECMED) and Departamento de Biología Celular, Facultat de Biología, Universidad de Valencia, 46100 Burjassot, Spain.
Mateos-White I; Neural Development Laboratory, Instituto Universitario de Biomedicina y Biotecnología (BIOTECMED) and Departamento de Biología Celular, Facultat de Biología, Universidad de Valencia, 46100 Burjassot, Spain.
Fabra-Beser J; Neural Development Laboratory, Instituto Universitario de Biomedicina y Biotecnología (BIOTECMED) and Departamento de Biología Celular, Facultat de Biología, Universidad de Valencia, 46100 Burjassot, Spain.
Gil-Sanz C; Neural Development Laboratory, Instituto Universitario de Biomedicina y Biotecnología (BIOTECMED) and Departamento de Biología Celular, Facultat de Biología, Universidad de Valencia, 46100 Burjassot, Spain.

Źródło:

Cells [Cells] 2021 Jan 10; Vol. 10 (1). Date of Electronic Publication: 2021 Jan 10.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't; Review

MeSH Terms:

Cell Adhesion Molecules/*metabolism
Neocortex/*embryology
Neocortex/*metabolism
Animals ; Humans ; Mammals/embryology ; Neurodevelopmental Disorders/metabolism ; Organogenesis ; Synapses/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

Poor Sleep Quality Experience and Self-Management Strategies in Fibromyalgia: A Qualitative Metasynthesis.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Poor Sleep Quality Experience and Self-Management Strategies in Fibromyalgia: A Qualitative Metasynthesis.

Autorzy:

Climent-Sanz C; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Morera-Amenós G; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Bellon F; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Pastells-Peiró R; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Blanco-Blanco J; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Valenzuela-Pascual F; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.
Gea-Sánchez M; Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.; Grup de Recerca de Cures en Salut, GRECS, Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré, 25198 Lleida, Spain.; Grup d'Estudis Societat, Salut, Educació i Cultura, GESEC, Department of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain.

Źródło:

Journal of clinical medicine [J Clin Med] 2020 Dec 10; Vol. 9 (12). Date of Electronic Publication: 2020 Dec 10.

Typ publikacji:

Journal Article; Review

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Sephin1 Protects Neurons against Excitotoxicity Independently of the Integrated Stress Response.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Sephin1 Protects Neurons against Excitotoxicity Independently of the Integrated Stress Response.

Autorzy:

Ruiz A; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.
Zuazo J; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.
Ortiz-Sanz C; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.
Luchena C; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.
Matute C; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.
Alberdi E; Departamento de Neurociencias, Universidad del País Vasco (UPV/EHU), Achucarro Basque Center for Neuroscience and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940 Leioa, Spain.

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2020 Aug 24; Vol. 21 (17). Date of Electronic Publication: 2020 Aug 24.

Typ publikacji:

Journal Article

MeSH Terms:

Endoplasmic Reticulum Stress/*drug effects
Guanabenz/*analogs & derivatives
Neurons/*drug effects
Neuroprotective Agents/*pharmacology
Stress, Physiological/*drug effects
Animals ; Calcium/metabolism ; Cells, Cultured ; Cytoprotection/drug effects ; Embryo, Mammalian ; Guanabenz/pharmacology ; N-Methylaspartate/metabolism ; N-Methylaspartate/pharmacology ; Neurons/metabolism ; Neurons/physiology ; Neurotoxicity Syndromes/metabolism ; Neurotoxicity Syndromes/pathology ; Rats ; Rats, Sprague-Dawley ; Signal Transduction/drug effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 47.

Tytuł:

Evaluating the impact of the weather conditions on the influenza propagation.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Evaluating the impact of the weather conditions on the influenza propagation.

Autorzy:

Singh DE; Carlos III University of Madrid, Leganés, Spain.
Marinescu MC; Barcelona Supercomputing Center, Barcelona, Spain. .
Carretero J; Carlos III University of Madrid, Leganés, Spain.
Delgado-Sanz C; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Gomez-Barroso D; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Larrauri A; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Źródło:

BMC infectious diseases [BMC Infect Dis] 2020 Apr 05; Vol. 20 (1), pp. 265. Date of Electronic Publication: 2020 Apr 05.

Typ publikacji:

Journal Article

MeSH Terms:

Weather*
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Epidemics ; Humans ; Humidity ; Middle Aged ; Models, Theoretical ; Sentinel Surveillance ; Spain/epidemiology ; Temperature ; Urban Population/statistics & numerical data ; Vaccination ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

Illness Severity in Hospitalized Influenza Patients by Virus Type and Subtype, Spain, 2010-2017.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Illness Severity in Hospitalized Influenza Patients by Virus Type and Subtype, Spain, 2010-2017.

Autorzy:

Delgado-Sanz C
Mazagatos-Ateca C
Oliva J
Gherasim A
Larrauri A

Źródło:

Emerging infectious diseases [Emerg Infect Dis] 2020 Feb; Vol. 26 (2), pp. 220-228.

Typ publikacji:

Journal Article

MeSH Terms:

Hospitalization*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Cohort Studies ; Female ; Humans ; Infant ; Infant, Newborn ; Influenza, Human/pathology ; Influenza, Human/virology ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Spain/epidemiology ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 49.

Tytuł:

Rabbit Enteropathies on Commercial Farms in the Iberian Peninsula: Etiological Agents Identified in 2018-2019.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

Rabbit Enteropathies on Commercial Farms in the Iberian Peninsula: Etiological Agents Identified in 2018-2019.

Autorzy:

Solans L; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Arnal JL; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Sanz C; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Benito A; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Chacón G; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Alzuguren O; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.
Fernández AB; Veterinary Diagnostic Disease and Autogenous Vaccine Laboratory, Exopol SL, Poligono Rio Gallego, D/8. 50840 San Mateo de Gallego, Zaragoza, Spain.

Źródło:

Animals : an open access journal from MDPI [Animals (Basel)] 2019 Dec 13; Vol. 9 (12). Date of Electronic Publication: 2019 Dec 13.

Typ publikacji:

Journal Article

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.

Czasopismo naukowe

• na półce

Szczegóły

Zmień widok

Tytuł:

The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.

Autorzy:

González M; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Ellahioui Y; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Departamento de Biología y Geología, Física y Química Inorgánica, ESCET, Universidad Rey Juan Carlos, Calle Tulipán s/n, E-28933. Móstoles, Madrid, Spain.
Álvarez R; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Gallego-Yerga L; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Caballero E; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Vicente-Blázquez A; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), E-28040 Madrid, Spain.
Ramudo L; Departamento de Fisiología y Farmacología, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Marín M; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Sanz C; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Medarde M; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Pelaéz R; Laboratorio de Química Orgánica y Farmacéutica, Departamento de Ciencias Farmacéuticas, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.; Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS). Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2019 Nov 26; Vol. 24 (23). Date of Electronic Publication: 2019 Nov 26.

Typ publikacji:

Journal Article

MeSH Terms:

Bibenzyls/*chemistry
Nitrogen/*chemistry
Tubulin/*metabolism
Tubulin Modulators/*chemistry
Apoptosis/drug effects ; Binding Sites ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cell Proliferation ; Colchicine/chemistry ; Drug Design ; HT29 Cells ; HeLa Cells ; Humans ; Ligands ; MCF-7 Cells ; Molecular Docking Simulation ; Pyridines/chemistry ; Solubility/drug effects ; Structure-Activity Relationship

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły